DIN 02462729 — DOBUTAMINE INJECTION USP 12.5 MG
DOBUTAMINE INJECTION USP is a solution of Dobutamine marketed by HIKMA CANADA LIMITED. The full Dobutamine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02462729
- Brand name
- DOBUTAMINE INJECTION USP
- Active ingredient
- Dobutamine
- Strength
- 12.5 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- HIKMA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Beta-1 adrenergic agonist (inotropic sympathomimetic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Dobutamine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02384671 | DOBUTAMINE INJECTION SDZ | 12.5 MG | SOLUTION | SANDOZ CANADA INCORPORATED | DORMANT |
| 02242010 | DOBUTAMINE INJECTION USP | 12.5 MG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED |